The up-regulation of CD36 has been evidenced on the sarcolemma of cardiomyocytes in diabetic mice and patients with DCM, which is owing to both high membrane translocation and high expression of CD36 triggered by hyperinsulinemia, hyperglycemia and hyperlipidemia during the development of diabetes (5, 48). This evidence concerns the gene CD36 and hyperinsulinism.